1. The Inside Scoop
  2. Health Tips for Women
  3. Endometriosis, PCOS, and Women’s Health: What You Need to Know
endometriosis, pcos

Endometriosis, PCOS, and Women’s Health: What You Need to Know

May 5, 2026

Key Takeaways

  • Endometriosis affects 10% of reproductive-age women worldwide, while PCOS affects 5-20% through hormonal imbalances.
  • Pain patterns differ significantly.
  • Both conditions can coexist in the same woman, with 7-8% of PCOS patients also having endometriosis, creating a 10-fold higher risk of fertility problems.
  • Early diagnosis is crucial, laparoscopy confirms endometriosis while PCOS requires meeting two of three criteria.
  • Treatment combines medical and lifestyle approaches.
An asian women experiencing abdominal pain
Inside Scoop

The Inside Rx Blog

Get the Inside Scoop on tips & tricks that may help your family save on prescriptions!

Subscribe to stay up to date with the latest news and tips

Research indicates 90% of women lack adequate information about women's health conditions. Endometriosis and polycystic ovary syndrome (PCOS) affect millions of reproductive-age women yet remain poorly understood across medical and patient populations. PCOS affects 5 to 20 percent of women during childbearing years, while endometriosis represents the primary cause of chronic pelvic pain in women. Both conditions create substantial disruptions to menstrual cycles, hormonal balance, and reproductive function.

Clinical presentation frequently overlaps between PCOS and endometriosis. Patients present with irregular menstrual patterns, pelvic pain, and systemic fatigue, complicating differential diagnosis. Accurate identification of these conditions requires systematic evaluation of symptomatology, hormonal profiles, and imaging studies. Medical professionals must distinguish between these disorders to implement appropriate therapeutic interventions and improve patient outcomes.

What is Endometriosis and What is PCOS

Understanding Endometriosis

Endometriosis develops when endometrial-like tissue establishes growth outside the uterine cavity. This ectopic tissue typically localizes on ovaries, fallopian tubes, pelvic peritoneum, and pouch of Douglas. Extragenital manifestations occur less frequently, affecting bowel, bladder, or pulmonary structures.

The displaced tissue exhibits hormonal responsiveness identical to intrauterine endometrium. Monthly cyclical changes include proliferation, secretory transformation, and desquamation. Without physiologic drainage pathways, cellular debris accumulates within the pelvic cavity. This process generates chronic inflammation, adhesion formation, and ovarian endometriomas.

Endometriosis affects an estimated 10% (190 million) of reproductive age women worldwide. Pathophysiology involves elevated estradiol concentrations, the primary estrogen driving endometrial proliferation. Infertility statistics demonstrate endometriosis prevalence ranges from 24% to 50% among affected women, establishing this disorder as a leading cause of reproductive dysfunction.

Understanding PCOS

Polycystic ovary syndrome represents a complex endocrine disorder characterized by androgen excess. The condition involves ovarian hyperandrogenism, where androgen production exceeds normal female physiologic levels. Ovarian morphology shows multiple subcapsular follicular cysts containing arrested oocytes that fail to complete maturation.

Clinical manifestations affect 5 million women and typically emerge during menarche. Menstrual dysfunction presents as oligomenorrhea (fewer than eight cycles annually) or amenorrhea, with cycle intervals extending beyond 35 days. Despite nomenclature referencing ovarian cysts, the fundamental pathophysiology involves insulin resistance and hyperandrogenism rather than cystic ovarian disease.

More than half of women with PCOS develop type 2 diabetes by age 40. Associated symptoms include hirsutism, acne vulgaris, androgenic alopecia, and central adiposity distribution. These manifestations reflect elevated androgen bioactivity across multiple target tissues.

How These Conditions Differ

Endometriosis and PCOS demonstrate distinct hormonal mechanisms despite shared reproductive system involvement. Endometriosis pathogenesis centers on estrogen dominance, particularly estradiol-mediated tissue proliferation. PCOS etiology involves androgen excess combined with insulin resistance, disrupting normal ovulatory mechanisms.

Pain presentation provides diagnostic differentiation. Endometriosis produces severe dysmenorrhea, dyspareunia, and dyschezia related to inflammatory processes and nerve involvement. PCOS rarely generates significant pelvic pain, instead presenting with metabolic dysfunction, menstrual irregularities, and hyperandrogenic symptoms including hirsutism and dermatologic changes.

Symptoms of PCOS vs Endometriosis

Clinical Manifestations of Endometriosis

Pelvic pain represents the primary diagnostic indicator of endometriosis. Dysmenorrhea (painful menstruation) exceeds normal menstrual discomfort and constitutes the most frequently reported symptom. Pain typically initiates before menstrual onset and persists throughout the cycle, radiating to the lumbar region and lower abdomen.

Dyspareunia (painful intercourse) affects a significant proportion of patients with endometriosis. Dyschezia and dysuria, pain during bowel movements and urination respectively, occur predominantly during menstrual periods. Gastrointestinal symptoms including constipation, diarrhea, abdominal distension, and nausea correlate with menstrual timing. Menorrhagia (heavy menstrual bleeding) and intermenstrual spotting occur frequently. Chronic fatigue presents as a secondary manifestation.

Clinical Manifestations of PCOS

Oligomenorrhea or amenorrhea characterizes PCOS, with patients experiencing fewer than eight menstrual cycles annually. Cycle length extends beyond 35 days or ceases entirely. Hirsutism, excessive hair growth on face, chest, back, and buttock results directly from hyperandrogenism. Acne and seborrhea (oily skin) develop secondary to androgen elevation.

Abdominal weight accumulation occurs commonly in PCOS patients. Androgenic alopecia (male-pattern hair loss) affects scalp hair distribution. Acanthosis nigricans, hyperpigmented skin patches, appears around neck folds and body creases.

Symptom Overlap Analysis

Menorrhagia, dysmenorrhea, and infertility present in both conditions. Between 30% to 50% of women with endometriosis experience reproductive difficulties. PCOS similarly impairs fertility through anovulation.

Concurrent Condition Presentation

Coexistence of both disorders occurs in clinical practice. Endometriosis prevalence reaches 7-8% among PCOS patients. Studies demonstrate a 10-fold increase in subfertility risk when both conditions present simultaneously. Among PCOS patients with chronic pelvic pain, 74% exhibit endometriosis lesions upon laparoscopic examination.

Causes, Risk Factors, and Getting Diagnosed

What Causes Endometriosis

Endometriosis etiology remains incompletely understood, though genetic predisposition demonstrates significant influence. First-degree relatives of women with endometriosis face 5 to 7 times higher likelihood of developing the condition. Twin studies reveal concordance rates between 75% and 88% in identical twins, establishing substantial heritability. The disorder exhibits polygenic/multifactorial inheritance patterns, where multiple genetic variants interact with environmental and hormonal influences.

Multiple pathogenic theories explain endometriosis development. Retrograde menstruation theory proposes menstrual blood flows retrograde through fallopian tubes into the pelvic cavity, enabling endometrial cell implantation at ectopic sites. Alternative mechanisms include embryonic cell transformation during pubertal development, immune system dysfunction preventing elimination of displaced tissue, and hematogenous or lymphatic transport of endometrial cells.

What Causes PCOS

PCOS pathophysiology centers on insulin resistance and androgen excess. 70% of women with PCOS exhibit insulin resistance, including those maintaining normal weight. Cellular insulin resistance triggers compensatory hyperinsulinemia, stimulating ovarian androgen production and disrupting normal ovulatory mechanisms. Familial clustering patterns indicate strong genetic components in PCOS development.

Risk Factors to Know

Endometriosis risk factors extend beyond family history. Early menarche (occurring before age 11), nulliparity, short menstrual cycles (less than 27 days), and prolonged menstrual bleeding exceeding seven days elevate risk. PCOS complications increase substantially with obesity. Women with concurrent obesity and PCOS demonstrate three-fold elevated type 2 diabetes risk, while normal-weight PCOS patients show no increased diabetes susceptibility.

How Doctors Diagnose These Conditions

Endometriosis diagnosis relies on laparoscopic visualization as the definitive standard. Surgical procedure involves small abdominal incisions, camera insertion, and direct tissue visualization or biopsy of suspected lesions. PCOS diagnosis requires fulfillment of two Rotterdam criteria: oligo-anovulation, clinical or biochemical hyperandrogenism, or polycystic ovarian morphology on ultrasound examination.

Effective condition management significantly improves patient outcomes. Inside Rx provides access to treatment options with potential savings up to 80% on women's health medications.

Treatment Options and Managing Your Health

Treating Endometriosis

Hormonal therapy represents the primary medical approach for endometriosis management. Oral contraceptives, transdermal patches, and vaginal rings provide hormonal regulation that reduces pain intensity. Gonadotropin-releasing hormone (GnRH) agonists induce temporary menopause, resulting in endometrial tissue shrinkage. Nonsteroidal anti-inflammatory drugs, including ibuprofen and naproxen, provide symptomatic relief for menstrual cramping. Laparoscopic conservative surgery removes endometriotic lesions while maintaining reproductive organ integrity, enhancing fertility potential and pain reduction.

Treating PCOS

PCOS management requires symptom-specific therapeutic approaches. Metformin addresses insulin resistance and can restore regular menstrual patterns. Combined oral contraceptives regulate menstrual cycles while reducing hirsutism and acne severity. Fertility treatment utilizes clomiphene citrate or letrozole for ovulation induction. Metformin combined with clomiphene constitutes first-line therapy for ovulation induction.

Lifestyle Changes That Help

Weight reduction of 5% produces significant PCOS symptom improvement. Regular physical activity reduces insulin resistance and enhances metabolic function across both conditions. Low-glycemic dietary protocols benefit PCOS patients through blood glucose stabilization. Anti-inflammatory nutrition, including fruits, vegetables, and omega-3 fatty acids, may provide endometriosis symptom relief.

How These Conditions Affect Fertility

Between 30% to 50% of women with endometriosis experience fertility impairment. PCOS accounts for 80% of anovulatory infertility cases. Endometriosis patients achieve IVF success rates of 50% to 60% per embryo transfer cycle.

When to See a Doctor

Medical consultation is indicated for severe pelvic pain, menstrual periods exceeding seven days, heavy bleeding requiring hourly pad changes, or conception difficulty after six months (women over 35) or twelve months (women under 35). Inside Rx provides access to treatment options with potential savings up to 80% on women's health medications.

The Inside Rx prescription discount card works like a coupon to save on the cost of prescription medication at your local pharmacy.

Yaz

$ 54.90
Blist Pack (28.0 Tablet), 0.02-3(28)
1 Blist Pack

Trulicity

$ 765.10
Pen Injector, 0.75mg/0.5 (Package Of 2.0 Ml)
1 Package

Conclusion

Endometriosis and PCOS create substantial clinical challenges affecting menstrual function, hormonal regulation, and reproductive health outcomes. Clinical symptoms including pelvic pain, menstrual irregularities, and systemic fatigue frequently receive inadequate medical attention, despite their significant impact on patient quality of life. Evidence-based treatment protocols can effectively manage both conditions when implemented through systematic healthcare evaluation. Patient education regarding these reproductive health disorders enables earlier recognition of clinical symptoms and facilitates appropriate medical consultation. Inside Rx provides access to women's health medications at reduced costs, patients may qualify for savings up to 80% on prescription treatments.

References